MINERALOCORTICOID RECEPTOR ANTAGONISM IN CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Gillis, Keith [1 ]
Lees, Jennifer [2 ]
Jardine, Alan [2 ]
Traynor, Jamie [1 ]
Mark, Patrick [2 ]
机构：
[1] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP111
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [21] Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension
    Shigeru Shibata
    Kenichi Ishizawa
    Shunya Uchida
    Hypertension Research, 2017, 40 : 221 - 225
  • [22] Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice
    Palacios-Ramirez, Roberto
    Lima-Posada, Ixchel
    Bonnard, Benjamin
    Genty, Marie
    Fernandez-Celis, Amaya
    Hartleib-Geschwindner, Judith
    Foufelle, Fabienne
    Lopez-Andres, Natalia
    Bamberg, Krister
    Jaisser, Frederic
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [23] Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
    Bertocchio, Jean-Philippe
    Warnock, David G.
    Jaisser, Frederic
    KIDNEY INTERNATIONAL, 2011, 79 (10) : 1051 - 1060
  • [24] Mineralocorticoid receptor antagonists for cardioprotection in chronic kidney disease: a step into the future
    Maria-Eleni Alexandrou
    Marieta P. Theodorakopoulou
    Mehmet Kanbay
    Pantelis A. Sarafidis
    Journal of Human Hypertension, 2022, 36 : 695 - 704
  • [25] Mineralocorticoid receptor antagonists for cardioprotection in chronic kidney disease: a step into the future
    Alexandrou, Maria-Eleni
    Theodorakopoulou, Marieta P.
    Kanbay, Mehmet
    Sarafidis, Pantelis A.
    JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (08) : 695 - 704
  • [26] Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease
    Raj, Rajesh
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (03): : 265 - 271
  • [27] Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease
    Rosenberg, Mai
    Bagrov, Alexei Y.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] The mineralocorticoid receptor in diabetic kidney disease
    Jia, Guanghong
    Lastra, Guido
    Bostick, Brian P.
    Lahamkaram, Nihay
    Laakkonen, Johanna P.
    Yla-Herttuala, Seppo
    Whaley-Connell, Adam
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 327 (03) : F519 - F531
  • [29] Mineralocorticoid antagonists in chronic kidney disease
    Al Dhaybi, Omar
    Bakris, George
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (01): : 50 - 55
  • [30] Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure
    Ferreira, Joao Pedro
    Santos, Mario
    Almeida, Sofia
    Marques, Irene
    Bettencourt, Paulo
    Carvalho, Henrique
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (01) : 67 - 72
12345